CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Open-market sale SVP and General Counsel sold 4,166 shares at $41.93 ($174,680)
- 4 Open-market sale Chief Scientific Officer sold 27,265 shares at an average $41.56 ($1,133,212)
- 4 Open-market sale SVP, Diagnostics, T-Detect sold 1,301 shares at $41.25 ($53,666)
- 4 Open-market sale Chief People Officer sold 2,000 shares at $43.04 ($86,080)
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at $44.50 ($89,000)
- 4 Open-market sale Director sold 4,500 shares at $43.41 ($195,345)
- 4 Open-market sale Chief Operating Officer sold 3,586 shares at $42.34 ($151,831)
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at an average $41.30 ($826,005)
- 4 Open-market sale CEO and Chairman sold 15,000 shares at an average $41.81 ($627,107)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP and General Counsel sold 4,167 shares at $40.00 ($166,680)
- 4 Open-market sale Chief Scientific Officer sold 19,475 shares at an average $40.36 ($786,061)
- 4 Grant or award Director acquired 4,443 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Diagnostics, immunoSEQ Dx sold 16,052 shares at an average $43.58 ($699,560)
- 4 Open-market sale CEO and Chairman sold 15,000 shares at an average $42.89 ($643,416)
- 4 Grant or award Director acquired 4,443 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 6,000 shares at an average $43.06 ($258,363)
- 4 Open-market sale Chief Business Development Off sold 1,354 shares at an average $41.69 ($56,451)
Page 13 of 28 · 544 filings